Petco Health and Wellness Company (WOOF) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
14 May, 2026Executive summary
The annual meeting is scheduled for June 30, 2026, and will be held virtually to maximize shareholder access and participation at no additional cost.
Shareholders will vote on four key proposals: election of directors, advisory approval of executive compensation, amendment to the equity incentive plan, and auditor ratification.
The board unanimously recommends voting in favor of all proposals.
The company is classified as a controlled company, with the principal stockholder holding over 51% voting power for director elections.
Voting matters and shareholder proposals
Proposal 1: Election of four Class III directors for three-year terms.
Proposal 2: Advisory vote on executive compensation (say-on-pay).
Proposal 3: Approval of the Second Amendment to the 2021 Equity Incentive Plan, increasing authorized shares by 15.5 million.
Proposal 4: Ratification of Ernst & Young LLP as independent auditor for fiscal year ending January 30, 2027.
Board recommends voting “FOR” all proposals.
Board of directors and corporate governance
Board consists of ten directors, four of whom are independent; average tenure is six years and average age is 57.
Board leadership structure separates Chairman and CEO roles.
Principal stockholder retains significant nomination and committee rights under a stockholder agreement.
Committees include audit, compensation, and nominating/governance, each with defined charters and responsibilities.
Director compensation includes cash retainers, committee fees, and annual equity grants; non-employee directors receive $100,000 annual cash retainer and $165,000 in RSUs.
Latest events from Petco Health and Wellness Company
- Director elections, executive pay, equity plan amendment, and auditor ratification up for vote.WOOF
Proxy filing14 May 2026 - Profitability and cash flow surged in 2025, with leverage ratio reduced to 3.0x.WOOF
Q4 202611 Mar 2026 - Q2 revenue fell, losses widened, and cost discipline intensified amid macroeconomic headwinds.WOOF
Q2 202521 Jan 2026 - Q3 revenue grew 1.2%, margin improved, and positive free cash flow is on track.WOOF
Q3 202511 Jan 2026 - Q4 2024 comp sales rose and free cash flow turned positive, but revenue and EBITDA declined.WOOF
Q4 202526 Dec 2025 - Profitability and cash flow improved in Q3 2025, despite a 3.1% sales decline.WOOF
Q3 20265 Dec 2025 - Board recommends approval of all proposals, emphasizing governance, pay-for-performance, and ESG.WOOF
Proxy Filing1 Dec 2025 - Joel D. Anderson named CEO effective July 29, 2024, with expanded Board and updated leadership.WOOF
Proxy Filing1 Dec 2025 - Virtual meeting to vote on directors, executive pay, and auditor ratification July 24, 2025.WOOF
Proxy Filing1 Dec 2025